MoneyWorks4Me

Gujarat Terce Labs. - Quaterly Results

08 Aug 2026 Evaluate
Net sales declined -17.06%  to  Rs. 90.02 million from Rs. 108.54 millions.The Net Loss for the quarter ended June 2026 is Rs. -1.77 millions as compared to Net Loss of Rs. -0.44 millions of corresponding quarter ended June 2025Operating profit Margin for the quarter ended June 2026 slipped to -0.10% as compared to 0.73% of corresponding quarter ended June 2025


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 90.02 108.54 -17.06 90.02 108.54 -17.06 474.73 501.95 -5.42
Other Income 4.82 0.95 407.37 4.82 0.95 407.37 3.40 3.08 10.39
PBIDT -0.10 0.73 -113.70 -0.10 0.73 -113.70 40.89 41.90 -2.41
Interest 0.32 0.49 -34.69 0.32 0.49 -34.69 1.80 4.15 -56.63
PBDT -0.42 0.24 -275.00 -0.42 0.24 -275.00 34.55 37.75 -8.48
Depreciation 1.06 0.96 10.42 1.06 0.96 10.42 4.23 3.85 9.87
PBT -1.48 -0.72 105.56 -1.48 -0.72 105.56 30.32 33.90 -10.56
TAX 0.29 -0.28 -203.57 0.29 -0.28 -203.57 8.31 43.69 -80.98
Deferred Tax 0.29 -0.28 -203.57 0.29 -0.28 -203.57 -2.57 7.88 -132.61
PAT -1.77 -0.44 302.27 -1.77 -0.44 302.27 22.01 -9.79 -324.82
Equity 77.91 74.20 5.00 77.91 74.20 5.00 77.91 74.20 5.00
PBIDTM(%) -0.11 0.67 -116.52 -0.11 0.67 -116.52 8.61 8.35 3.19

Gujarat Terce Labs. Share Price

42.98 1.93 (4.70%)
07-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1949.00
Dr. Reddys Labs. 1172.00
Cipla 1472.00
Lupin 2360.00
Zydus Lifesciences 1115.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: